CD38 inhibitor 78c manufacturers
- CD38 inhibitor 1
-
- $51.00
-
2026-05-06
- CAS:1700637-55-3
- Purity: 99.99%
- Supply Ability: 10g
- CD38 inhibitor 1
-
- $51.00
-
2026-04-20
- CAS:1700637-55-3
- Purity: 99.99%
- Supply Ability: 10g
- CD38
-
-
2025-03-16
- CAS:1700637-55-3
- Min. Order: 1mg
- Purity: 98
- Supply Ability: 100G
|
| | CD38 inhibitor 78c Basic information |
| Product Name: | CD38 inhibitor 78c | | Synonyms: | 2(1H)-Quinolinone, 4-[[trans-4-(2-methoxyethoxy)cyclohexyl]amino]-1-methyl-6-(5-thiazolyl)-;4-[[trans-4-(2-methoxyethoxy)cyclohexyl]amino]-1-methyl-6-(5-thiazolyl)-2(1H)-Quinolinone;4-((trans-4-(2-Methoxyethoxy)cyclohexyl)amino)-1-methyl-6-(thiazol-5-yl)quinolin-2(1H)-one;4-[[trans-4-(2-Methoxyethoxy)cyclohexyl]amino]-1-methyl-6-(5-thiazolyl)quinolin-2(1H)-one;4- (trans 4- (2-methoxyethoxy) cyclohexyl) amino) -1-methyl-6- (thiazol-5-yl) quinoline-2 (1H) - one;Cluster of Differentiation 38 Inhibitor;Compound-78c;MDK 7553 | | CAS: | 1700637-55-3 | | MF: | C22H27N3O3S | | MW: | 413.53 | | EINECS: | | | Product Categories: | | | Mol File: | 1700637-55-3.mol |  |
| | CD38 inhibitor 78c Chemical Properties |
| Boiling point | 589.8±50.0 °C(Predicted) | | density | 1.27±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 25 mg/mL (60.46 mM; ultrasonic and warming and heat to 60°C) | | form | A solid | | pka | 3.17±0.20(Predicted) | | color | Light yellow to brown | | InChI | InChI=1S/C22H27N3O3S/c1-25-20-8-3-15(21-13-23-14-29-21)11-18(20)19(12-22(25)26)24-16-4-6-17(7-5-16)28-10-9-27-2/h3,8,11-14,16-17,24H,4-7,9-10H2,1-2H3/t16-,17- | | InChIKey | VJQALSOBHVEJQM-QAQDUYKDSA-N | | SMILES | N1(C)C2=C(C=C(C3SC=NC=3)C=C2)C(N[C@@H]2CC[C@@H](OCCOC)CC2)=CC1=O |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | CD38 inhibitor 78c Usage And Synthesis |
| Description |
Thiazoloquin(az)olin(on)es, such as the small molecule 78c, have been identified as potent CD38 inhibitors (CD38i). CD38 inhibitor 78c is a potent, reversible, and uncompetitive inhibitor of CD38. 78c reverses age-related NAD+ decline and ameliorates several metabolic, structural, and molecular ageing features in chronologically aged and progeroid mice. The CD38 inhibitor 78c increases naturally aged mice's lifespan and health span. In addition to a 10% increase in median survival, 78c improved exercise performance, endurance, and metabolic function in mice. The effects of 78c were different between the sexes[1-2].
| | Uses | 4-[[trans-4-(2-methoxyethoxy)cyclohexyl]amino]-1-methyl-6-(5-thiazolyl)-2(1H)-Quinolinone is a useful compound and has been evaluated for use as CD38 inhibitors. | | in vivo | CD38 inhibitor (30 mg/kg; oral administration; 2 and 6 hours) significantly elevates NAD levels in liver and muscle[1]. | Animal Model: | Diet induced obese (DIO) C57Bl6 mice[1] | | Dosage: | 30 mg/kg | | Administration: | Orally once | | Result: | NAD levels were significantly increased at both the 2 and 6 h time points in liver and muscle. |
| | storage | Store at -20°C | | References |
[1] Thais R. Peclat. “CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging.” Aging Cell 21 4 (2022).
[2] Mariana G Tarragó. “A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline.” Cell metabolism 27 5 (2018): 1081-1095.e10.
|
| | CD38 inhibitor 78c Preparation Products And Raw materials |
|